Pulse Biosciences, Inc. (PLSE)

Pulse Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,106	674	103	439	605	279
Market Cap Growth	385.87%	553.77%	-76.50%	-27.42%	116.90%	18.21%
Enterprise Value	1,035	633	109	409	587	248
Last Close Price	17.98	12.24	2.77	14.81	23.86	13.41
PS Ratio	-	-	147.32	309.48	-	-
PB Ratio	13.98	15.20	-45.87	12.30	26.41	9.07
P/TBV Ratio	14.34	16.99	-	14.78	37.28	11.91
EV/Sales Ratio	-	-	156.14	288.38	-	-
Debt / Equity Ratio	0.11	0.21	-33.79	0.32	0.50	0.22
Asset Turnover	-	-	0.01	0.03	-	-
Quick Ratio	11.72	6.61	10.22	3.37	2.70	5.70
Current Ratio	11.93	6.76	10.39	4.30	2.95	5.92
Return on Equity (ROE)	-70.28%	-200.47%	-349.89%	-217.33%	-185.90%	-96.78%
Return on Assets (ROA)	-38.15%	-39.75%	-54.93%	-82.44%	-75.06%	-53.26%
Return on Capital (ROIC)	-40.70%	-42.82%	-60.15%	-97.02%	-87.10%	-57.75%
Earnings Yield	-4.17%	-6.26%	-56.73%	-14.51%	-8.24%	-16.85%
FCF Yield	-3.08%	-4.92%	-45.98%	-12.43%	-5.92%	-12.48%
Buyback Yield / Dilution	-23.82%	-41.56%	-21.35%	-20.29%	-12.06%	-21.48%
Total Shareholder Return	-23.82%	-41.56%	-21.35%	-20.29%	-12.06%	-21.48%

Source: S&P Capital IQ. Standard template. Financial Sources.